Literature DB >> 21035171

Screening history in women with cervical cancer in a Danish population-based screening program.

Benny Kirschner1, Susanne Poll, Carsten Rygaard, Anne Wåhlin, Jette Junge.   

Abstract

OBJECTIVE: The aim of this study was to explore the screening histories of all cervical cancers in a Danish screening population. The intention was to decide suboptimal sides of the screening program and to evaluate the significance of routine screening in the development of cervical cancer.
METHODS: The study describes the results of a quality control audit, performed on all new cervical cancer cases diagnosed in the years 2008-2009 at two major Danish screening-centers. All relevant cytological and histological cervical samples were reviewed.
RESULTS: 202.534 cytological samples were evaluated in the study period, while 112 women were diagnosed with cervical cancer. The histological diagnoses comprised: 62 (55.4%) squamous cell carcinomas, 20 (17.9%) microinvasive squamous cell carcinomas, 25 (22.3%) adenocarcinomas and 5 cancers of different histology. The mean age of study subjects was 46.6 years. 51 (45.5%) women had deficient screening histories, while 45 (40.2%) women had followed the screening recommendations and had normal cervical samples in review. 11 (9.8%) women were diagnosed with false negative cytology, 2 women had false negative histological tests, while pathological review was not feasible for 3 subjects.
CONCLUSIONS: More than 45% of the cervical cancer cases in our study were due to deficient cervical screening, stressing the importance of increasing the screening-uptake and coverage. 40% interval cancers emphasize the relevance of further cervical testing of women with relevant symptoms, despite of prior normal cervical samples. Finally, 9.8% false negative cytological samples are consistent with previous reports, but still a part of the screening program that should be improved.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21035171     DOI: 10.1016/j.ygyno.2010.09.021

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  12 in total

Review 1.  False Negative Results in Cervical Cancer Screening-Risks, Reasons and Implications for Clinical Practice and Public Health.

Authors:  Anna Macios; Andrzej Nowakowski
Journal:  Diagnostics (Basel)       Date:  2022-06-20

2.  Association of insurance status and age with cervical cancer stage at diagnosis: National Cancer Database, 2000-2007.

Authors:  Stacey A Fedewa; Vilma Cokkinides; Katherine S Virgo; Priti Bandi; Debbie Saslow; Elizabeth M Ward
Journal:  Am J Public Health       Date:  2012-06-28       Impact factor: 9.308

3.  Underscreened Women Remain Overrepresented in the Pool of Cervical Cancer Cases in Spain: A Need to Rethink the Screening Interventions.

Authors:  Raquel Ibáñez; María Alejo; Neus Combalia; Xavier Tarroch; Josefina Autonell; Laia Codina; Montserrat Culubret; Francesc Xavier Bosch; Silvia de Sanjosé
Journal:  Biomed Res Int       Date:  2015-06-09       Impact factor: 3.411

4.  Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above.

Authors:  Matejka Rebolj; Jesper Bonde; Sarah Preisler; Ditte Ejegod; Carsten Rygaard; Elsebeth Lynge
Journal:  PLoS One       Date:  2016-01-20       Impact factor: 3.240

5.  Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.

Authors:  Mette Tranberg; Bodil Hammer Bech; Jan Blaakær; Jørgen Skov Jensen; Hans Svanholm; Berit Andersen
Journal:  BMC Cancer       Date:  2016-11-03       Impact factor: 4.430

6.  Quality control of cervical cytology using a 3-type HPV mRNA test increases screening program sensitivity of cervical intraepithelial neoplasia grade 2+ in young Norwegian women-A cohort study.

Authors:  Bjørn Westre; Anita Giske; Hilde Guttormsen; Sveinung Wergeland Sørbye; Finn Egil Skjeldestad
Journal:  PLoS One       Date:  2019-11-05       Impact factor: 3.240

7.  [Evaluation of mortality after the analysis of the screening history in women diagnosed with infiltrating cervical cancer].

Authors:  Marta Castillo; Aurora Astudillo; Omar Clavero; Julio Velasco; Raquel Ibáñez; Silvia de Sanjosé
Journal:  Aten Primaria       Date:  2017-06-16       Impact factor: 1.137

8.  Protecting the underscreened women in developed countries: the value of HPV test.

Authors:  Raquel Ibáñez; Josefina Autonell; Montserrat Sardà; Nayade Crespo; Pilar Pique; Amparo Pascual; Clara Martí; Montserrat Fibla; Cristina Gutiérrez; Belén Lloveras; Judit Moreno-Crespi; Anna Torrent; Núria Baixeras; María Alejo; Francesc Xavier Bosch; Silvia de Sanjosé
Journal:  BMC Cancer       Date:  2014-08-08       Impact factor: 4.430

9.  Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening.

Authors:  Marta Castillo; Aurora Astudillo; Omar Clavero; Julio Velasco; Raquel Ibáñez; Silvia de Sanjosé
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

10.  Screening history and FIGO-stages among Danish women with cervical cancer in 2012-2014: a register-based study.

Authors:  Abir Khalil Bchtawi; Sinem Saritas; Doris Schledermann; René dePont Christensen; Kirsten Marie Jochumsen
Journal:  Sci Rep       Date:  2019-12-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.